APA

Makras P., Polyzos S. A. & Anastasilakis A. D. (20180507). Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism.

Chicago

Makras Polyzois, Polyzos Stergios A and Anastasilakis Athanasios D. 20180507. Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism.

Harvard

Makras P., Polyzos S. A. and Anastasilakis A. D. (20180507). Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism.

MLA

Makras Polyzois, Polyzos Stergios A and Anastasilakis Athanasios D. Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism. 20180507.